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PP1 and PP2A-B56 are major serine/threonine phos-
phatase families that achieve specificity by colocaliz-
ing with substrates. At the kinetochore, however,
both phosphatases localize to an almost identical
molecular space and yet they still manage to regulate
unique pathways and processes. By switching or
modulating the positions of PP1/PP2A-B56 at kinet-
ochores, we show that their unique downstream
effects are not due to either the identity of the phos-
phatase or its precise location. Instead, these phos-
phatases signal differently because their kinetochore
recruitment can be either inhibited (PP1) or enhanced
(PP2A) by phosphorylation inputs. Mathematical
modeling explains how these inverse phospho-de-
pendencies elicit unique forms of cross-regulation
and feedback, which allows otherwise indistinguish-
able phosphatases to produce distinct network be-
haviors and control different mitotic processes.
Furthermore, our genome-wide analysis suggests
that these major phosphatase families may have
evolved to respond to phosphorylation inputs in
opposite ways because many other PP1 and PP2A-
B56-binding motifs are also phospho-regulated.INTRODUCTION
Protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A)
are large phosphatase families that are responsible for most of
the serine/threonine dephosphorylation in eukaryotic cells (Brau-
tigan and Shenolikar, 2018; Heroes et al., 2013). This is exempli-
fied by the fact that PP2A inhibition causes approximately half of
the phosphorylation sites in the human proteome to change
significantly (Kauko et al., 2018). PP1 and PP2A use structurally
related catalytic domains that are remarkably well-conserved
and relatively promiscuous in vitro (Ingebritsen and Cohen,
1983). In vivo, however, they are believed to achieve specificity2206 Cell Reports 28, 2206–2219, August 20, 2019 ª 2019 The Autho
This is an open access article under the CC BY license (http://creativeby interacting with short linear motifs (SLiMs) that localize them
to their required sites of action (Brautigan and Shenolikar,
2018). The best-characterized SLiM for PP1 is the RVxF motif,
which is present in approximately 90% of the validated PP1-in-
teracting proteins (Heroes et al., 2013). The best-characterized
SLiM for PP2A is the LxxIxE motif, which binds to the regulatory
subunit of the PP2A-B56 holoenzyme complex (Hertz et al.,
2016).
This simplistic model of co-localization driving function ex-
plains nicely how these phosphatases can target specific sub-
strates, but it does not explain why these substrates select to
interact specifically with one phosphatase over the other when
their catalytic activities are apparently very similar. In that sense,
it fails to capture the essence of why PP1 andPP2A have evolved
to regulate different signals. They must presumably possess
specific features that are repeatedly selected for by different
pathways throughout the course of evolution, although exactly
what these features are still remains unclear. It is important to
address this because it may help to reveal why these two major
phosphatase families have evolved to fulfil different signaling
roles.
One major distinction between PP1 and PP2A is their ability to
be regulated differently. This can occur directly on the holoen-
zymes; for example, via catalytic subunit phosphorylation or
the binding of catalytic inhibitors (Verbinnen et al., 2017; Rogers
et al., 2016; Grallert et al., 2015). A well-studied example of this is
the inhibition of PP2A-B55 during mitosis by the ARPP19/ENSA
phospho-proteins (Gharbi-Ayachi et al., 2010; Mochida et al.,
2010). Although direct regulation of the holoenzyme is useful
for modulating global phosphatase activity, there are many situ-
ationswhen individual pathways or substratesmust be regulated
separately. In these cases, the regulation can occur directly on
the SLiMs within these pathways that are needed to direct the
phosphatases toward specific substrates. Interestingly, in this
respect, PP1 and PP2A-B56 behave in opposite ways; PP1 bind-
ing to the RVxF motif can be repressed by phosphorylation (Kim
et al., 2003; Nasa et al., 2018), whereas PP2A-B56 interaction
with the LxxIxEmotif can be enhanced by phosphorylation (Hertz
et al., 2016; Wang et al., 2016a, 2016b). These unique modes of
phospho-regulation could allow PP1 and PP2A-B56 to perform
very different signaling roles; however, it is difficult to dissociaters.
commons.org/licenses/by/4.0/).
whether it is these properties or others, such as catalytic prefer-
ences, that are more important in any given situation.
To investigate this further, we chose to focus on the kineto-
chore, which is a multi-complex structure assembled on
chromosomes during mitosis to mediate their attachment to mi-
crotubules. Although this complex contains over 100 different
proteins, PP1 and PP2A-B56 are recruited via their SLiMs to
the same molecular scaffold, KNL1, to regulate kinetochore-
microtubule attachments and the spindle assembly checkpoint
(SAC) (Saurin, 2018). These processes are critical for genome
stability becausemicrotubules bind to kinetochores to segregate
the duplicated chromosomes equally, and the SAC holds the
mitotic state to give time for these microtubules to attach
correctly. Importantly, even though PP1 and PP2A are recruited
to a very similar molecular space on kinetochores, they still
appear to control these key mitotic processes differently, as evi-
denced by the fact that removing either phosphatase produces
markedly distinct phenotypic effects (these will be discussed in
detail below) (Saurin, 2018). It is currently unclear how these
phosphatases achieve specificity in such a crowded molecular
environment or, indeed, why they are both needed to carry out
different roles at the kinetochore. We therefore rationalized
that this would be an ideal system to reveal answers about phos-
phatase specificity and functional diversity within the broader
signaling context.
Using the direct approach of switching the phosphatases or
their SLiMs at the kinetochore, we demonstrate that their
unique phenotypic effects cannot be explained by either
catalytic preferences or positional differences. Instead, we
demonstrate that phenotypic diversity arises because the
phosphatases are recruited via SLiMs that display opposite
phospho-dependencies and, as a result, are subject to different
forms of cross-regulation and feedback. Therefore, this study
explains how downstream ‘‘specificities’’ can depend entirely
on the mode of upstream regulation, and it establishes a para-
digm to explain how these two major phosphatase families may
have evolved to couple to phosphorylation inputs in opposite
ways.
RESULTS
PP1-KNL1 and PP2A-B56 Exert Control over Different
Kinetochore Processes
KNL1 is a key signaling scaffold that functions at kinetochores
to generate the SAC signal and regulate the attachment of
microtubules. Critical for both of these processes are the
‘‘MELT’’ motifs (for the consensus sequence Met-Glu-Leu-Thr)
that are scattered along the N-terminal half of KNL1 and phos-
phorylated by MPS1 kinase to recruit the BUB1/BUBR1/BUB3
complex (London et al., 2012; Shepperd et al., 2012; Yamagishi
et al., 2012; Overlack et al., 2015; Primorac et al., 2013; Zhang
et al., 2014; Vleugel et al., 2013). This complex has two main
functions: (1) it modulates Aurora B activity to regulate kineto-
chore-microtubule attachments (Aurora B is a kinase that can
phosphorylate kinetochores to detach microtubule fibers; Krenn
and Musacchio, 2015), and (2) it provides a platform to recruit all
other proteins needed for the SAC to delay mitotic exit (Saurin,
2018). Crucially, both of these functions are regulated by twoco-localized phosphatase complexes: PP1, which is bound to
the SILK and RVSF motifs in the N terminus of KNL1 (PP1-
KNL1; note that Aurora B phosphorylates these motifs to inhibit
PP1 binding; Liu et al., 2010; Espeut et al., 2012; Meadows
et al., 2011; Nijenhuis et al., 2014; Rosenberg et al., 2011),
and PP2A-B56, which binds to an LSPIIE motif in BUBR1
(note that CDK1 and PLK1 both phosphorylate this motif to
enhance PP2A-B56 interaction; Foley et al., 2011; Kruse et al.,
2013; Suijkerbuijk et al., 2012; Xu et al., 2013; Nijenhuis et al.,
2014; Espert et al., 2014). There has been debate surrounding
exactly which phosphatase controls which process (Saurin,
2018); therefore, we begin by carefully dissecting their individual
roles at the kinetochore.
As shown previously by others (Shrestha et al., 2017),
removal of the PP2A-B56 SLiM in BUBR1 (BUBR1DPP2A) causes
severe defects in chromosome alignment whereas inactivation
of the PP1 SLiM in KNL1 (KNL1DPP1) does not (Figure 1A; note
that, in these and all subsequent experiments, siRNA-mediated
gene knockdown was used in combination with doxycycline-
inducible replacement of the mutant gene from an FRT locus;
STAR Methods). Interestingly, we observed that these defects
are associated with enhanced phosphorylation of the NDC80
tail region (Figures 1B and S1A), a key Aurora B substrate that
must be dephosphorylated to stabilize kinetochore-microtubule
attachments (Krenn and Musacchio, 2015). In contrast to these
differential effects on chromosome alignment, PP1-KNL1 and
PP2A-B56 are both needed to allow KNL1 MELT dephosphory-
lation and SAC silencing following inhibition of the upstream ki-
nase MPS1 (Figures 1C, 1D, S1B, and S1C; Espert et al., 2014;
Nijenhuis et al., 2014). However, even in this situation, the
BUBR1DPP2A and KNL1DPP1 phenotypes differ because the ef-
fects of PP2A-B56 loss can be specifically rescued by Aurora
B inhibition (Figures 1E, 1F, S1D, and S1E; note that this is
not due to differential effects on microtubule attachments
because all SAC assays were performed in nocodazole to
depolymerize microtubules). We hypothesized previously that
PP2A-B56 sits upstream of PP1 in SAC silencing by suppress-
ing Aurora B-mediated phosphorylation of KNL1 to allow PP1-
KNL1 association (Nijenhuis et al., 2014). This is consistent
with the results shown in Figure 1G, which show that mutating
these Aurora B sites in KNL1 (KNL1PP1(2A)) allows nocodazole-
arrested BUBR1DPP2A cells to exit mitosis rapidly following
MPS1 inhibition. Therefore, rescuing PP1-KNL1 can bypass
the requirement for PP2A-B56 in SAC silencing. Importantly,
the same is not true in reverse because PP2A-B56 is present
on kinetochores in KNL1DPP1 cells (Figures 1H and S1F), and
yet these cells can still not silence the SAC (Figure 1D; Nijenhuis
et al., 2014).
In summary, PP1 and PP2A-B56 are recruited via their respec-
tive SLiMs to a very similar molecular space on kinetochores
and yet they still manage to exert control over different sub-
strates and different mitotic processes. PP2A-B56 antagonizes
Aurora B signals to regulate kinetochore-microtubule attach-
ments and PP1-KNL1 interaction, whereas PP1-KNL1 antago-
nizes MPS1 signals to silence the SAC (Figure 1I). PP2A-B56
may also contribute to SAC silencing directly, but it cannot
support MELT dephosphorylation without PP1-KNL1 (Figures
1D and 1H). Similarly, PP1-KNL1 could help to stabilize initialCell Reports 28, 2206–2219, August 20, 2019 2207
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Figure 1. PP1-KNL1 and PP2A-B56 Exert Control over Different Pathways and Processes at the Kinetochore
(A and B) Effect of phosphatase-bindingmutants on chromosomal alignment (A) and pSer55-NDC80 kinetochore levels in nocodazole (B). The graph in (A) shows
the mean (SD) of 3 experiments, at least 100 cells per condition per experiment. The graph in (B) shows data from 60 cells per condition from 4 experiments.
(C–F) Effect of phosphatase-binding mutants on KNL1-MELT dephosphorylation in nocodazole-arrested cells treated with the MPS1 inhibitor AZ-3146 (2.5 mM)
for the indicated times, either alone (C and D) or in combination with the Aurora B inhibitor ZM-447439 (2 mM, E and F). MG132 was included in all treatments to
prevent Cyclin B degradation and mitotic exit following MPS1 inhibition. The graphs in C–E include 30 cells per condition from 3 experiments.
(G) Duration of mitotic arrest in cells expressing various WT and phosphatase-binding mutant combinations and treated with nocodazole and 2.5 mM AZ-3146.
The graph shows the cumulative mean (±SEM) of 4 experiments, 50 cells per condition per experiment.
(H) Kinetochore B56g levels in nocodazole-arrested cells expressing WT or PP1 binding-deficient KNL1 (KNL1DPP1). The graph shows 75 cells per condition from
4 experiments.
(I) A schematic model depicting the primary effects of PP1 and PP2A-B56 on the KMNnetwork. PP2A-B56 is shown to regulate Aurora B directly, but this is simply
meant to represent co-antagonism of both Aurora B substrates at the kinetochore (pRVSF and pNDC80). KT, kinetochore; MT, microtubule.
For all kinetochore intensity graphs, each dot represents a cell, and the error bars display the variation between the experimental repeats (displayed as ±SD of the
experimental means). Not significant, ns, p > 0.05; *p < 0.05.microtubule attachments, but it is not essential, and it is also not
able to support proper chromosome alignment in the absence of
PP2A-B56 (Figure 1A). Therefore, both of these potential links
are still included in the model shown in Figure 1I, but only as
dotted arrows.2208 Cell Reports 28, 2206–2219, August 20, 2019PP1 and PP2A-B56Can Functionally Substitute for Each
Other at Kinetochores
The simplest explanation for the observed phenotypic differ-
ences is that PP1 and PP2A are different catalytic enzymes
that could produce specific effects at the kinetochore. Therefore,
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Figure 2. PP1 and PP2A-B56 Can Functionally Substitute for Each Other at the Kinetochore
(A) Effect of altering the phosphatase at BUBR1 on chromosomal alignment. The graph shows the mean (SD) of 3 experiments, with at least 100 cells per
condition per experiment.
(B and C) Effect of altering the phosphatase at KNL1 on SAC phenotypes.
(B) KNL1-MELT dephosphorylation in nocodazole-arrested cells treated with the MPS1 inhibitor AZ-3146 (2.5 mM) for the indicated times. The graph shows
30 cells per condition from 3 experiments.
(C) Duration of mitotic arrest in cells treated with nocodazole and 5 mM AZ-3146. The graph shows the cumulative mean (±SEM) of 3 experiments, 50 cells per
condition per experiment.
(D and E) Effect of altering the phosphatase at BUBR1 on SAC phenotypes.
(D) KNL1-MELT dephosphorylation in nocodazole-arrested cells treated with the MPS1 inhibitor AZ-3146 (2.5 mM) for the indicated times. The graph shows 50–
60 cells per condition from 6 experiments.
(E) Duration of mitotic arrest in cells treated with nocodazole and 2.5 mM AZ-3146. The graph shows the cumulative mean (±SEM) of 4 experiments, 50 cells per
condition per experiment.
MG132 was included in treatments in (B) and (D) to prevent Cyclin B degradation and mitotic exit following MPS1 inhibition. For all kinetochore intensity graphs,
each dot represents a cell, and the errors bars display the variation between the experimental repeats (displayed as ± SD of the experimental means).to test whether the identity of the phosphatase is a key determi-
nant of its function, we deleted the SLiMs that recruit PP1 or
PP2A-B56 to kinetochores and asked whether the resulting phe-
notypes could be rescued when the alternative phosphatase isrecruited in its place. Figure 2A shows that the chromosome
alignment defects following truncation of BUBR1 before the
PP2A-B56 binding region (BUBR1DCT) can be rescued when a
short region from the KNL1 N terminus is fused in its place toCell Reports 28, 2206–2219, August 20, 2019 2209
recruit PP1 (BUBR1DCT-PP1:KNL1; note that the Aurora B sites are
mutated in the SLiMs to prevent Aurora B from inhibiting PP1
binding). This is dependent on PP1 binding because the effect
is lost when the N-terminal fusion has the PP1-binding SLiM
mutated (BUBR1DCT-KNL1) to prevent PP1 recruitment (Figure 2A;
see Figure S2A and S2B for a demonstration of phosphatase
switching under these conditions). Conversely, if the first 70
amino acids of the KNL1 N terminus are removed, which con-
tains the PP1 binding region (KNL1DNT), then SAC silencing
and MELT dephosphorylation are inhibited following MPS1 inhi-
bition (Figures 2B, 2C, and S2C). However, if B56 is tethered
directly to the N terminus of KNL1 (B56g-KNL1DNT), then both
of these effects can be fully rescued (Figures 2B, 2C, and
S2C). This requires PP2A catalytic activity because fusion of a
B56 mutant that cannot bind the catalytic domain (B56gCD-
KNL1DNT; Vallardi et al., 2019) does not support SAC silencing.
Finally, preventing PP2A-B56 recruitment to BUBR1 also gives
a SAC silencing defect, and this can also be fully rescued by re-
cruiting PP1 in its place (Figures 2D, 2E, and S2D). Therefore,
both phosphatases can functionally substitute for each other
when their respective positions at the kinetochore are switched.
This demonstrates that the phenotypic differences cannot be ex-
plained by the identity of the individual phosphatases.
PP1 and PP2A-B56 Can Function from Different
Positions at the KMN Network
If identity is not important for function, then the precise positions
may be critical instead. For example, although PP1 or PP2A are
recruited to the same molecular subcomplex on kinetochores,
theymay only have restricted access to a subset of different sub-
strates from their exact positions on KNL1 and BUBR1. To
address this, we first focused on kinetochore-microtubule
attachment regulation because this was clearly defective when
phosphatases were absent from the BUBR1 position (Figures
1A and 2A). Importantly, however, this position does not appear
to be critical because chromosomal alignment defects in
BUBR1DPP2A cells could be rescued when B56 was recruited
to the N terminus of KNL1 instead (B56g-KNL1DNT) (Figure 3A).
Therefore, PP2A-B56 can support chromosomal alignment
from either the BUBR1 or KNL1 position.
We next examined why PP1-KNL1 was sufficient on its own to
support SAC silencing whereas PP2A-B56 bound to BUBR1was
not (Figures 1C–1H). The SLiM that recruits PP1 is conserved at
the N terminus of KNL1 throughout evolution (Figures 3B and
S3A); therefore, we hypothesized that this position may be crit-
ical to access the MELTs. Surprisingly, however, moving the
PP1-binding SLiM into the middle of KNL1 (KNL1DNT-PP1mid)
had little effect on MELT dephosphorylation (Figure 3C), Bub
complex removal from kinetochores (Figures S3B–S3E), or
SAC silencing (Figures 3D and S3F) following MPS1 inhibition
in nocodazole. Neither did it affect the ability of Aurora B to regu-
late the recruitment of BUB1/BUBR1 to KNL1 (Figures S3G and
S3H). Therefore, PP1 does not need to be positioned at the
N terminus of KNL1 to silence the SAC in the absence of micro-
tubules. Although the exact position does not appear to be
important, the phosphatase could still require a unique feature
of KNL1 itself to silence the SAC, such as its predicted flexibility.
This might explain why PP2A-B56 bound to BUBR1 could not2210 Cell Reports 28, 2206–2219, August 20, 2019dephosphorylate the MELT motifs in KNL1DPP1 cells (Figures
1D and 1H). Although we had already observed that PP1 can
silence the SAC when bound to BUBR1 (Figures 2D and 2E),
this effect might be direct or indirect because PP1 could simply
dephosphorylate the SILK/RVSF motifs to recruit an additional
PP1 molecule to KNL1. To distinguish between these possibil-
ities, we created double-mutant cells in which the BUBR1 phos-
phatase could be switched in either the presence or absence
of PP1-KNL1. Importantly, SAC silencing was still rescued in
KNL1DPP1 cells by a BUBR1 mutant that recruits PP1 even
though it could not be recovered in the same cells by a BUBR1
wild type (WT) that can bind to PP2A-B56 (Figure 3E). Therefore,
PP1 can silence the SAC directly when positioned at either KNL1
or BUBR1.
In summary, PP1 and PP2A-B56 have specific functions at the
kinetochore (Figure 1), but these cannot be explained by differ-
ences in either their catalytic subunits (Figure 2) or their spatial
positioning (Figure 3). This is surprising because these are
thought to be the principal determinants of phosphatase speci-
ficity, and if these phosphatases do not display any obvious
specificity, then it is not easy to rationalize why they produce dif-
ferential effects at the kinetochore. Furthermore, if the identity of
the phosphatase is not important, as Figure 2 demonstrates,
then it is not clear why there is such a difference in the ability
of PP1 or PP2A to support kinetochore-microtubule attachment
from the KNL1 N terminus (compare both BUBR1DPP2A condi-
tions in Figure 3A) and SAC silencing from the BUBR1 position
(compare both KNL1DPP1 conditions in Figure 3E). However, as
well as switching phosphatases in these key experiments, we
also abolished their regulation by phosphorylation inputs. In
particular, Aurora B phosphorylates the KNL1-SLiMs to inhibit
PP1 (Liu et al., 2010), but when microtubule attachments were
rescued by recruitment of PP2A-B56 to KNL1, we directly teth-
ered B56 and lost these regulatory inputs (Figure 3A). In addition,
CDK1 and PLK1 phosphorylate the BUBR1-SLiM to recruit
PP2A-B56 (Huang et al., 2008; Elowe et al., 2007; Kruse et al.,
2013; Suijkerbuijk et al., 2012; Wang et al., 2016a, 2016b), but
when the SAC was rescued by recruiting PP1 to BUBR1, we
removed this phospho-dependence (Figure 3E). Therefore, we
rationalized that it may be the unique forms of SLiM regulation
that prevent PP1-KNL1 from stabilizingmicrotubule attachments
when PP2A-B56 is removed and restrict PP2A-B56 from
silencing the SAC when PP1-KNL1 is absent.
PP1-KNL1 and PP2A-B56 Use Opposite
Phospho-Dependencies to Control Distinct Kinetochore
Processes
A major difference in their SLiM regulation is that phosphoryla-
tion of KNL1 represses PP1 binding, whereas phosphorylation
of BUBR1 enhances PP2A-B56 binding. Therefore, even when
these phosphatases display no downstream specificity at kinet-
ochores, removal of their SLiMs will enhance phosphorylation of
the opposing SLiM and produce opposite effects on phospha-
tase localization (Figure 4A). Indeed, inhibiting BUBR1:PP2A-
B56 interaction is known to enhance Aurora B-mediated
phosphorylation of the KNL1 SLiM to prevent PP1 binding (Nijen-
huis et al., 2014). This is not a specific effect of PP2A-B56
per se because removal of PP2A-B56 from BUBR1 enhances
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Figure 3. The Exact Positions of PP1 and PP2A-B56 Are Not Critical for Their Kinetochore Functions
(A) Chromosomal alignment after removing PP2A-B56 from BUBR1 and repositioning it at KNL1. The graph shows the mean (SD) of 3 experiments, at least
100 cells per condition per experiment.
(B) Conservation of the RVxF SLiM at the N terminus of KNL1. Sequences are colored using the ClustalW scheme.
(C and D) Effect of relocating the PP1 SLiMs to the middle of KNL1 on SAC phenotypes.
(C) KNL1-MELT dephosphorylation in nocodazole-arrested cells treated with the MPS1 inhibitor AZ-3146 (5 mM) for the indicated times. The graph shows 30–
40 cells per condition from 4 experiments. MG132was included to prevent Cyclin B degradation andmitotic exit following MPS1 inhibition. Each dot represents a
cell, and the errors bars display the variation between the experimental repeats (displayed as ± SD of the experimental means).
(D) Duration of mitotic arrest in cells treated with nocodazole and 5 mM AZ-3146.
(E) Effect of switching PP1 from KNL1 to BUBR1 on SAC silencing. Shown is the duration of mitotic arrest in cells expressing different WT and mutant com-
binations and treated with nocodazole and 2.5 mM AZ-3146.
The graphs in (D) and (E) show the cumulativemean (±SEM) of 3 experiments (D) or 8 experiments (E), 50 cells per condition per experiment. ns, p > 0.05; *p < 0.05.KNL1-RVSF phosphorylation, and this can be rescued by re-
cruiting PP1 to BUBR1 instead (Figure 4B). Therefore, inhibiting
phosphatase activity at BUBR1 also inhibits it at KNL1 becausethe PP1:SLiM interaction is repressed by phosphorylation.
Importantly, if these phosphorylation sites aremutated to alanine
to rescue PP1-KNL1 in BUBR1DPP2A cells (KNL1PP1(2A)), thenCell Reports 28, 2206–2219, August 20, 2019 2211
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Figure 4. PP1-KNL1 and PP2A-B56 Use Opposite Phospho-dependencies to Control Distinct Processes at the Kinetochore
(A) Schematic to illustrate how cross-regulation between SLiMs affects kinetochore phosphatase levels.
(B) Effect of altering the phosphatase at BUBR1 on KNL1-pRVSF kinetochore levels in nocodazole. The graph shows data from 40 cells per condition from 4
experiments. Each dot represents a cell, and the error bars display the variation between the experimental repeats (displayed as ±SD of the experimental means).
(C) Chromosome alignment in cells expressing mutant combinations to prevent phosphorylation of the PP1 SLiMs following removal of PP2A-B56 from BUBR1.
The graph shows the mean (SD) of 3 experiments, at least 100 cells per condition per experiment.
(D and E) Effect of removing the phospho-dependence of PP2A-B56 on SAC silencing by either direct BUBR1-B56g fusion (D) or mutation of the PP2A-binding
SLiM in BUBR1 (E). Shown is the duration of mitotic arrest in cells expressing various WT and mutant combinations and treated with nocodazole and 2.5 mM
AZ-3146. The graphs show the cumulative mean (±SEM) of 3 experiments, 38–50 cells per condition per experiment. The BubR1-WT controls in (D) were also
used in some experiments shown in Figure 3E (see Data S2 for details).chromosome alignment defects are also recovered (Figure 4C).
Therefore, either phosphatase in either position can support
chromosomal alignment (Figures 2A, 3A, and 4C). There appears
to be a specific role for PP2A-B56 because when it is removed2212 Cell Reports 28, 2206–2219, August 20, 2019from BUBR1, then PP1-KNL1 is also lost (assuming that
Aurora B is active on kinetochores to phosphorylate the KNL1
SLiMs). In contrast, PP1-KNL1 is redundant because even
when it is removed, PP2A-B56 is still preserved on kinetochores
to antagonize Aurora B (Figure 1H). Therefore, the different forms
of SLiM interaction explain why chromosomal alignment is pri-
marily controlled by distinct phosphatase complexes at kineto-
chores (Figure 1A).
To determine the reason for the differential effect on the SAC,
we focused on the crucial observation that PP1-KNL1 inhibition
prevents SAC silencing even though PP2A-B56 remains bound
to BUBR1 at kinetochores (Figures 1D and 1H).We hypothesized
that the phospho-dependence of this BUBR1 interaction re-
stricts PP2A-B56 from efficiently silencing the SAC, which is
supported by the observation that PP1 can silence the SAC
when recruited to BUBR1 in a manner that is independent of
phosphorylation (BUBR1DCT-PP1:KNL1; Figure 3E). In agreement
with this hypothesis, a similar effect is also observed when B56
is fused directly to BUBR1 (BUBR1DCT-B56g; Figure 4D), which
demonstrates that PP1 and PP2A-B56 can both silence the SAC
efficiently when tethered directly to BUBR1, even in KNL1DPP1
cells. These fusions eliminate the dependence on phosphoryla-
tion for phosphatase recruitment, but, in addition, they also
change the relative orientation of the phosphatases at BUBR1.
This could, in principle, provide the additional flexibility needed
for access to key substrates that might otherwise be inacces-
sible when B56 is bound to the LxxIxE motif. Increased flexibility
is unlikely to explain why PP2A-B56 cannot silence the SAC,
however, given that insertion of a flexible linker immediately
before the PP2A binding motif in BUBR1 does not affect MELT
dephosphorylation or SAC silencing in either the presence or
absence of PP1-KNL1 (Figure S4). Nevertheless, to test directly
whether lack of phospho-dependence was the reason for
enhanced SAC silencing, we mutated the PP2A binding
sequence in BUBR1 to an LxxIxE sequence that binds to B56
in the same manner and with similar affinities but, crucially,
does not depend on phosphorylation (BUBR1deP-PP2A, which
uses an LPTIHE sequence; Kruse et al., 2018). Figure 4E shows
that BUBR1deP-PP2A cells were now able to silence the SAC in the
absence of PP1-KNL1, demonstrating that PP2A-B56 is
restricted from silencing the SAC because of a phospho-depen-
dent interaction with BUBR1. There is still an additional contribu-
tion of PP1-KNL1 in this situation (compare BUBR1deP-PP2A in
KNL1WT and KNL1DPP1 cells), which likely indicates that both
phosphatases collaborate to shut down the SAC. This is pre-
dicted given that both phosphatases are indistinguishable in
our assayswhen they are coupled in either position, independent
of phosphorylation (Figures 2B–2E).
In summary, although PP1 and PP2A-B56 are indistinguish-
able in our assays when their positions are switched (Figure 2),
they can still produce distinct effects because they couple to
phosphorylation inputs in opposite ways (Figure 4). Therefore,
we next sought to address whether this alone was sufficient to
explain their phenotypic differences at kinetochores. To this
end, we developed a mathematical model of the network out-
lined in Figure 1I. A crucial aspect of this model, which is
displayed schematically in Figure 5A, is that both phosphatases
dephosphorylate the same substrates (KNL1-pMELT, KNL1-
pRVSF, BUBR1-pLSPI, and pNDC80) with identical kinetics
when docked to their native SLiMs on KNL1. This binding occurs
directly for PP1 (via dephospho-KNL1-RVSF) or indirectly for
PP2A (via phospho-KNL1-MELT and phospho-BUBR1-LSPI).The kinases that phosphorylate these docking motifs (MPS1,
Aurora B, and CDK1) are given a fixed activity that is not regu-
lated by the phosphatases or any other aspect of the model.
Therefore, any difference between the two phosphatases in the
model is due to their inverse phospho-dependencies, as sug-
gested by all results presented so far.
Modeling to Show How Identical Phosphatases with
Opposite Phospho-dependencies Can Produce Distinct
Phenotypic Behaviors
We first asked whether the model could reproduce the SAC data
from Figures 1C–1F. In our simulations, KNL1-MELT is dephos-
phorylated rapidly upon MPS1 inhibition, and this is dependent
on the presence of both PP1 and PP2A. Combined Aurora B in-
hibition speeds up the rate of MELT dephosphorylation and
specifically rescues the effects of PP2A loss (Figures 5B and
5C). Therefore, the model can reproduce the core data, which
crucially, also includes one key unexplained aspect of our re-
sults: PP2A-B56 is unable to silence the SAC in the absence of
PP1. We were able to explore this further in the model to demon-
strate that negative feedback loops downstream of PP2A
prevent this phosphatase from efficiently silencing the SAC.
Negative feedback occurs at multiple levels because PP2A de-
phosphorylates both BUBR1 and KNL1 to effectively remove
and inhibit its own recruiting SLiM (this occurs directly and indi-
rectly via PP1; Figure 5D).We had already determined howmuch
of an effect these feedback loops have on PP2A-B56 localization
by quantifying kinetochore B56g levels following expression of
a WT or inactive B56 mutant (B56gCD; Figure S5) and then
including this difference in the model. Now, by selectively
removing the loops, we can measure their effects on the output.
This demonstrates that preventing the feedback onto phospho-
BUBR1 reduces phospho-MELT levels (Figure 5E), which is
consistent with the fact that PP2A can silence the SAC effectively
in BUBR1-B56 or BUBR1deP-PP2A cells (Figures 4D and 4E).
However, a stronger effect on MELT dephosphorylation is
observed when all negative feedback loops are abolished by re-
cruiting a phosphatase that is independent of either phospho-
BUBR1 or phospho-KNL1 (Figure 5E). In this case, there is
also a significantly increased sensitivity to changes in MPS1
levels. This is effectively the situation that is achieved when
Aurora B is inhibited and PP1-KNL1 recruitment to kinetochores
is unconstrained, as can be seen in the WT situation with
Aurora B inhibition (Figure 5E).
Therefore, the model illustrates how negative feedback down-
stream of PP2A could allow the SAC to remain robust to
variations in MPS1 activity (i.e., KNL1-pMELT levels remain
high when MPS1 levels decrease; Figure 5E) by limiting the abil-
ity of this phosphatase to dephosphorylate the MELTs on its
own. When Aurora B activity falls at kinetochores, then PP1
recruitment is elevated, and the SAC can be efficiently silenced
without the effects of negative feedback restricting phosphatase
levels. In fact, this transition is aided by positive feedback
instead because PP1 dephosphorylates the KNL1-RVSF motif
to enhance its own recruitment (Figure 5D). Using parameters
identical to the SAC simulation (STAR Methods), the model
also simulates the cross-regulation that is illustrated in Figure 4A.
In the absence of PP2A, PP1 levels are dramatically reduced,Cell Reports 28, 2206–2219, August 20, 2019 2213
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Figure 5. Mathematical Model Showing How Identical Phosphatases with Opposite Phospho-dependencies Can Produce Distinct
Phenotypic Behaviors
(A) Full wiring diagram underlying the mathematical model that assumes identical activities of PP1 and PP2A toward all kinetochore substrates. Their only dif-
ferences are their opposite modes of phospho-regulation. Arrowswith dotted ends represent reversible binding/dissociation reactions. Regular arrows represent
phosphorylation/dephosphorylation reactions catalyzed by the kinases/phosphatases, as indicated.
(B and C) Comparison of the simulated output with the real data from Figures 1C–1F. The graphs show KNL1-MELT dephosphorylation after MPS1 inhibition (B)
and MPS1 + Aurora B inhibition (C).
(D) Schematic illustrating the various positive and negative feedback loops that affect phosphatase recruitment. Note that both phosphatases act on all
phosphorylation sites.
(E) Simulated steady-state levels of KNL1-pMELT as a function of MPS1 for different conditions to remove negative feedback or inhibit Aurora B. Sensitivity/
robustness can be compared directly because it corresponds to the slope of the curve on the log-scale graph.
(F) Simulated kinetochore levels of PP1 or PP2A after removal of either phosphatase. The simulated output confirms the predictions for cross-regulation in
Figure 4A.
(G) Comparison of simulated pNDC80 steady-state values during a SAC arrest (i.e., MPS1 and Aurora B active) with the experimental data from Figure 1B.
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whereas in the absence of PP1, PP2A levels are increased (Fig-
ure 5F). This is consistent with the data from Figure 1H and leads
to a differential effect on steady-state pNDC80 levels (Figure 5G).
This is also consistent with our observed differential effects on
kinetochore-microtubule attachments and NDC80 phosphoryla-
tion (Figures 1A and 1B).
The simulation therefore illustrates how identical phospha-
tases can produce differential phenotypic behaviors by using
opposite modes of phospho-regulation. Considering that we
observed no other differences between PP1 and PP2A-B56 in
any of our assays, this implies that kinetochores have evolved
to interact with these phosphatases primarily because of their in-
verse phospho-dependencies. This has important implications
for signaling in general because it is likely that many other path-
ways have also selected for these key defining features.
Phospho-regulation Is a Common Feature of RVxF and
LxxIxE SLiMs
To analyze this further, we curated a list of validated and pre-
dicted RVxF and LxxIxE motifs that are present in almost 700
unique proteins (Table S1). Motif analysis demonstrates that ser-
ines and threonines are statistically enriched at positions within
each motif where phosphorylation is known to inhibit (RVxF) or
enhance (LxxIxE) phosphatase interaction (Figures 6A and 6B;
Kim et al., 2003; Nasa et al., 2018; Hertz et al., 2016; Wang
et al., 2016a, 2016b; Kumar et al., 2016). Furthermore, up to
25% of the validated motifs are known to be phosphorylated
in vivo, and 50% of the RVxF and 100% of the LxxIxE motifs
contain phosphorylatable residues at the key positions (Figures
6C–6E), which is a statistically significant enrichment (see amino
acid matrices in Table S1). It should be noted that phosphoryla-
tion of residues outside of the core RVxF region can also inhibit
PP1 binding (Kumar et al., 2016; Qian et al., 2015; Vagnarelli
et al., 2011). Furthermore, the negatively charged surface that
surrounds the RVxF pocket on PP1 (Figure 6F) could potentially
mediate many other electrostatic interactions that are inhibitable
by phosphorylation. Therefore, although only half of the core
RVxF motifs contain phosphorylatable residues, the percentage
that are phospho-regulatable is probably much higher. In
contrast to PP1, the interaction between PP2A-B56 and LxxIxE
motifs can be enhanced by phosphorylation inside of and imme-
diately after the core motif. This is because the charged phos-
phate residues in the P2 andP7–P9 positions canmake key elec-
trostatic interactions with basic residues in a groove on B56
(Hertz et al., 2016; Wang et al., 2016a, 2016b; Figure 6G). There-
fore, the binding pockets on PP1 and B56 appear to have
evolved to respond to phosphorylated SLiMs in opposite ways,
and numerous pathways have likely taken advantage of these
unique properties to enable localized phosphatase activity to
be modulated by different kinase inputs. This study therefore
provides a paradigm that could explain how two of the main
phosphatase families in eukaryotic cells have evolved to perform
very important but also very distinct signaling roles.
DISCUSSION
The integration of kinase and phosphatase signals is a critical
aspect of signal transduction (Gelens et al., 2018). At the kineto-chore, numerous kinase and phosphatase signals converge at
the KMN network to regulate two key mitotic processes (Saurin,
2018). We show here that the two distinct phosphatases, in this
case, are used for their ability to positively or negatively respond
to kinase inputs. Although the kinases themselves clearly play an
important role in determining phosphatase function, as will be
discussed further below, it is important to point out that the dif-
ferential effects illustrated here are primarily caused by cross-
regulation and feedback between phosphatases.
The cross-regulation occurs because the phosphatases are
embedded in the same network and can therefore dephosphor-
ylate the respective SLiMs to produce opposing effects on each
other’s recruitment (Figures 4A and 5F). In particular, PP2A can
dephosphorylate the SILK and RVSF SLiMs to enhance PP1-
KNL1 levels and exert control over net phosphatase activity at
the KMN network. This control is relinquished upon loss of
Aurora B activity because these SLiMs are no longer phosphor-
ylated, which ensures that PP1-KNL1 can then be recruited inde-
pendently of PP2A-B56. This is likely to be important to allow
SAC silencing and microtubule stability to be maintained when
PP2A-B56 is removed from kinetochores under tension.
In addition to cross-regulation, their unique phospho-depen-
dencies also elicit different forms of feedback regulation. There
are many feedback loops to consider (Figure 5D), but the under-
lying theme is that phosphatase activity helps to enhance PP1
and repress PP2A. As a consequence, PP2A is subjected to a
variety of negative feedback loops, which, as our modeling sug-
gests, could be one reason that this phosphatase cannot effi-
ciently dephosphorylate the MELT motifs on its own following
MPS1 inhibition. This contrasts with PP1, which engages in pos-
itive feedback and can dephosphorylate the MELT motifs in a
more responsive manner (Figure 5E). Aurora B activity safe-
guards the transition from PP2A to PP1 at kinetochores, which
illustrates why it plays a key role in determining whether the
SAC is robust or responsive to declining MPS1 activity. This
has two important implications. (1) Tension is ultimately required
to inhibit Aurora B and allow the SAC to be silenced efficiently.
This may explain why the SAC remains active on mono-orien-
tated attachments and why it still takes hours to exit mitosis
when stable attachments are formed that cannot generate
tension (Tauchman et al., 2015; Etemad and Kops, 2016). (2)
Aurora B is a potentially dangerous node in the network that
could be hijacked by cancer cells to weaken the SAC and
generate hyper-stable kinetochore-microtubule attachments
(Cordeiro et al., 2018). These two effects can collaborate to
generate high levels of chromosomal instability; therefore, it
will be important in the future to determine whether Aurora B ac-
tivity is commonly deregulated in cancer cells.
Another important implication of this work is that kinetochore-
microtubule attachments and the SAC are principally regulated
by different phosphatase complexes. We show that, despite
their lack of specificity, PP2A-B56 is essential to stabilize micro-
tubule attachments, but PP1-KNL1 is then ultimately required to
help shut down the SAC. A similar separation of function was
recently demonstrated in yeast, but, in this case, between
different PP1 complexes (Roy et al., 2018). The general principle
is the same in both cases, however, because sequential regula-
tion by different phosphatases is predicted to guard againstCell Reports 28, 2206–2219, August 20, 2019 2215
Figure 6. Analysis of the Specificity Determinants and Phosphorylation Sites in PP1 RVxF and PP2A-B56 LxxIxE Motifs
(A) A log10 relative binomial sequence logo based on 110 validated PP1-binding RVxF motifs. Asterisks denote the significance of the amino acid enrichment of
basic (KR), acidic (DE), and phosphorylatable by Ser/Thr kinases (ST) (*p < 0.01, **p < 0.001, *** p < 0.0001). The logo is colored using ClustalW coloring.
(B) As in (A), built using 27 validated PP2A-B56-binding LxxIxE motifs.
(C) Sequence of the 22 RVxFmotifs with experimentally validated phosphorylation siteswithin the region of themotif (the region defined by the black line under the
logo in A). Consensus positions are indicated by boxes colored according to the ClustalW coloring scheme. Phosphorylated sites are indicated with orange
diamonds.
(D) As in C, but for the 8 LxxIxE motifs with experimentally validated phosphorylation sites.
(E) Summary of the LxxIxE and RVxF motifs phosphorylated (experimentally validated) and phosphorylatable (ST) within the motif regions (defined by the black
lines under the logos in A and B). Data are shown for validated motifs (blue bars) and a set of high-confidence predicted motifs (gray bars) created using the
PSSMSearch software (Krystkowiak et al., 2018) by using the validated motifs as input and filtering as described in Hertz et al. (2016).
(F) Structure of the RVxF motif of Rb bound to PP1 showing the key side chains of the motif that interact with the binding pocket (PDB: 3N5U; Hirschi et al., 2010).
(G) Structure of the LxxIxE motif of BUBR1 bound to B56, showing the key side chains of the motif that interact with the binding pocket (PDB: 5JJA; Wang et al.,
2016a). Structures are rendered using Coulombic surface coloring in the Chimera package to show the surface charge around the motif binding pockets.inappropriate SAC silencing when microtubule attachments are
not correct.
The work presented here implies that kinetochores have
evolved to interact with PP1 and PP2A-B56 mainly because of
their opposite phospho-dependencies. However, it is important2216 Cell Reports 28, 2206–2219, August 20, 2019to clarify that, although these phosphatases were fully inter-
changeable in all our experiments, this does not exclude the
possibility that important differences exist that were simply not
detected in our assays. The relative activities of each phospha-
tase toward key phosphorylation sites on KNL1 seem to be
identical (Figures 2B, 2D, and 4B), but there are probably other
important substrates that remain to be measured. Furthermore,
there are other established regulatory mechanisms that do not
involve the SLiMs but that could be needed for some aspects
of kinetochore regulation (Grallert et al., 2015; Porter et al.,
2013). The notion that important differences could simply have
been missed by our assays is illustrated nicely by our experi-
ments on the RVSF motif in KNL1. The N-terminal position of
this SLiM is not important for SAC silencing in the absence of mi-
crotubules, but the strict conservation at this position throughout
evolution indicates that there is an essential requirement that still
remains to be discovered (Figures 3C, 3D, and S3). Interestingly,
themicrotubule binding site on KNL1 has been shown recently to
overlap the PP1-binding SLiMs (Bajaj et al., 2018). Therefore, we
speculate that microtubules might need to compete with PP1 at
the N terminus. For example, they may need to elongate the
KNL1 structure and disrupt PP1 binding at the same time. It
will be interesting to test how this competition could affect
Aurora B regulation, error correction, and tension sensing.
Although other properties of PP1 and PP2A could be impor-
tant in some contexts, their inverse phospho-dependencies
are clearly the defining features with regard to the SAC and kinet-
ochore-microtubule attachments. This explains why the relevant
phosphorylation sites are so well-conserved within each kineto-
chore SLiM (Figure 3B; Suijkerbuijk et al., 2012).What then, is the
relevance of the particular kinase inputs needed to phosphory-
late these SLiMs? As discussed previously, Aurora B may regu-
late the PP1 SLiMs to allow the SAC phosphatase to respond to
tension. We speculate that PLK1 and CDK1 may similarly regu-
late the PP2A-B56 SLiM to allow the kinetochore-microtubule
phosphatase to respond to microtubule attachment. This is pre-
dicted given that both kinases are recruited to kinetochores in an
attachment-sensitive manner (Allan et al., 2019; Jackman et al.,
2019; Alfonso-Pe´rez et al., 2019; Le´na´rt et al., 2007; Liu et al.,
2012). In fact, both are also recruited to the KMN network in a
phosphorylation-dependent manner: Cyclin B/CDK1 interacts
with Mad1, a phospho-dependent interactor of BUB1, and
CDK1 can phosphorylate BUB1 to recruit PLK1 (Allan et al.,
2019; Jackman et al., 2019; Alfonso-Pe´rez et al., 2019; Saurin,
2018). Interestingly, the key Mad1-BUB1 interaction has also
been shown to be negatively regulated by kinetochore PP2A-
B56 (Qian et al., 2017). Therefore, PP2A may also counteract
CDK1 and PLK1 activity to create yet more negative feedback
to restrict its activity. This would serve to restrict PP2A from
silencing the SAC even more, which could allow the current
mathematical model to better approximate the real data. It
should be stressed that this model is just a basic framework to
explore how inverse phospho-dependencies could affect phos-
phatase behaviors. The output of themodeling should be viewed
as a proof of principle rather than proof of behavior. In the future,
details of how the various kinase inputs respond to phosphatase
activity should be layered into this model to provide amore com-
plete picture of signal integration at the KMN network.
Finally, if kinetochores have selected to interact with PP1 and
PP2A-B56 because of their inverse phospho-dependencies,
then many other pathways have likely exploited the same fea-
tures. This would explain the prevalence of phosphorylation sites
within validated and predicted RVxF and LxxIxE SLiMs (Figures6C–6E; Table S1). The invariant SLiM residues place some con-
straints on the type of kinase inputs that are tolerated within the
motifs themselves (Figure S6), but phosphorylation outside of
these regions can also regulate phosphatase binding (Kumar
et al., 2016; Qian et al., 2015; Vagnarelli et al., 2011). Further-
more, PP1 uses co-operative interaction with other SLiMs, and
some of these, such as the SILK motif in KNL1, are also phos-
pho-inhibitable (Liu et al., 2010). Therefore, these additional in-
teractions could allow a wide range of kinase inputs to converge
and fine-tune PP1 binding strength. This is analogous to the
contribution of both CDK1 and PLK1 to PP2A-B56 binding on
BUBR1 (Huang et al., 2008; Elowe et al., 2007; Kruse et al.,
2013; Suijkerbuijk et al., 2012; Wang et al., 2016a, 2016b). It
will be important in the future to fully characterize all possible
SLiM interactors for both PP1 and PP2A-B56 and to determine
how these can be regulated by different kinases. As pointed
out recently, kinases and phosphatases work together in many
different ways to generate the right type of signal response (Ge-
lens et al., 2018; Gelens and Saurin, 2018). Therefore, the ability
of different phosphatases to positively or negatively couple to
phosphorylation inputs represents a fundamental but still poorly
understood aspect of signal integration.
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php?page=instances
N/A
Experimental Models: Cell Lines
Human: HeLa Flp-in Empty Gift from S. Taylor Tighe et al., 2008
HeLa Flp-In YFP-BUBR1WT Nijenhuis et al., 2014 N/A
HeLa Flp-In YFP-BUBR1DPP2A Nijenhuis et al., 2014 N/A
HeLa Flp-In YFP-BUBR1 DCT This study N/A
HeLa Flp-In YFP-BUBR1Long This study N/A
HeLa Flp-In YFP-BUBR1deP-PP2A This study N/A
HeLa Flp-In YFP-KNL1WT This study N/A
HeLa Flp-In YFP-KNL1DPP1 This study N/A
HeLa Flp-In YFP-KNL1PP1(2A) This study N/A
HeLa Flp-In YFP-KNL1 DNT This study N/A
HeLa Flp-In YFP-B56g1-KNL1
DNT This study N/A
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
HeLa Flp-In YFP-B56 g1
CD-KNL1DNT This study N/A
HeLa Flp-In YFP-KNL1 DNT-PP1mid This study N/A
HeLa Flp-In YFP-BUBR1DCT-PP1:KNL1 This study N/A
HeLa Flp-In YFP-BUBR1DCT-KNL1 This study N/A
HeLa Flp-In YFP-BUBR1DCT-B56g1 This study N/A
HeLa Flp-In YFP-KNL1WT + mCherry-B56g1 This study N/A
HeLa Flp-In YFP-KNL1DPP1 + mCherry-B56g1 This study N/A
HeLa Flp-In YFP-BUBR1WT + mCherry-B56g1 This study N/A
HeLa Flp-In YFP-BUBR1 DCT + mCherry-B56g1 This study N/A
HeLa Flp-In YFP-BUBR1 DCT-PP1:KNL1 + mCherry-B56g1 This study N/A
HeLa Flp-In YFP-BUBR1 DCT-KNL1 + mCherry-B56g1 This study N/A
HeLa Flp-In YFP-B56g1 Vallardi et al., 2019 N/A
HeLa Flp-In YFP-B56g1
CD Vallardi et al., 2019 N/A
Oligonucleotides
siRNA targeting sequence: BUBR1 Sigma-Aldrich N/A
dsiRNA targeting sequence: KNL1 Integrated DNA technologies N/A
Recombinant DNA
pcDNA5-YFP-BUBR1WT Nijenhuis et al., 2014 N/A
pcDNA5-YFP-BUBR1DPP2A Nijenhuis et al., 2014 N/A
pcDNA5-YFP-BUBR1 DCT This study N/A
pcDNA5-YFP-BUBR1Long This study N/A
pcDNA5-YFP-BUBR1deP-PP2A This study N/A
pcDNA5-YFP-KNL1WT This study N/A
pcDNA5-YFP-KNL1DPP1 This study N/A
pcDNA5-YFP-KNL1PP1(2A) This study N/A
pcDNA5-YFP-KNL1 DNT This study N/A
pcDNA5-YFP-B56g1-KNL1
DNT This study N/A
pcDNA5-YFP-B56 g1
CD-KNL1DNT This study N/A
pcDNA5-YFP-KNL1 DNT-PP1mid This study N/A
pcDNA5-YFP-BUBR1DCT-PP1:KNL1 This study N/A
pcDNA5-YFP-BUBR1DCT-KNL1 This study N/A
pcDNA5-YFP-BUBR1DCT-B56g1 This study N/A
pMESVJ-mCherry-B56g1 This study N/A
pcDNA3-2xRFP-PP1gWT Nijenhuis et al., 2014 N/A
pcDNA4-mTurquoise2-BUBR1WT This study N/A
pcDNA5-mTurquoise2-BUBR1 deP-PP2A This study N/A
pcDNA5-mTurquoise2-BUBR1DCT-B56g1 This study N/A
pcDNA4-mTurquoise2-BUBR1DCT This study N/A
pcDNA4-mTurquoise2-BUBR1Long This study N/A
pcDNA4-mTurquoise2-BUBR1DCT-PP1:KNL1 This study N/A
pcDNA4-mTurquoise2-BUBR1DCT-KNL1 This study N/A
pcDNA5-YFP-B56g1 Vallardi et al., 2019 N/A
pcDNA5-YFP-B56g1
CD Vallardi et al., 2019 N/A
pOG44 Flp-Recombinase expression vector Thermo Fisher Cat# V600520
Software and algorithms
GraphPad Prism 6 GraphPad Software N/A
Fiji Schindelin et al., 2012 https://imagej.net/Fiji
Micro-Manager Edelstein et al., 2010 https://micro-manager.org/
Sloppycell Myers et al., 2007 http://sloppycell.sourceforge.net/
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LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Adrian
Saurin (a.saurin@dundee.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
All cell lines were derived from HeLa Flp-in cells (Sex = female; a gift from S Taylor, University of Manchester, UK) (Tighe et al., 2008),
which were authenticated by STR profiling (Eurofins). The cells were cultured in DMEM supplemented with 9% FBS and 50 mg/ml
penicillin/streptomycin. During fluorescence time-lapse analysis, cells were cultured in Leibovitz’s L-15 media (900 mg/L D+ Galac-
tose, 5mM Sodium Pyruvate, no phenol red) or DMEM (no phenol red) supplemented with 9% FBS and 50mg/ml penicillin/strepto-
mycin. Cells were screened every 4-8 weeks to ensure they were mycoplasma free.
METHOD DETAILS
Plasmids and cloning
pcDNA5-YFP-BUBR1WT expressing an N-terminally YFP-tagged and siRNA-resistant wild-type BUBR1 and pcDNA5-YFP-
BUBR1DPP2A (also called BUBR1DKARD), lacking amino acids 663-680 were described previously (Nijenhuis et al., 2014). All the re-
maining YFP-BUBR1 mutants were subcloned by PCR amplification of DNA fragments followed by a Gibson assembly reaction
to insert back into the original vector (pcDNA5-YFP-BUBR1WT), except when indicated. pcDNA5-YFP-BUBR1 DCT, was subcloned
from pcDNA5-YFP-BUBR1WT by PCR amplification of the BUBR1 fragment (excluding amino acids 664-1050). pcDNA5-YFP-
BUBR1Long was constructed by insertion of a flexible 36 amino acid [GSG]-linker between amino acids 663 and 664. pcDNA5-
YFP-BUBR1deP-PP2A was generated by site directed mutagenesis of the pcDNA5-YFP-BUBR1WT vector mutating the KARD motif
from 50-SIKKLSPIIEDSR-30 to 50-RSSTLPTIHEEEE-30 (Kruse et al., 2018).
pcDNA5-YFP-KNL1WT expressing an N-terminally YFP-tagged and siRNA-resistant wild-type KNL1, pcDNA5-YFP-KNL1PP1(2A)
(with S25A and S60A mutations, also called KNL12SA) and pcDNA5-YFP-KNL1DPP1 (with RVSF at amino acids 58-61 mutated to
AAAA, also called KNL14A) were described previously (Nijenhuis et al., 2014). Site directed mutagenesis was used to further improve
the resistance of pcDNA5-YFP-KNL1WT construct to dsiRNA by modifying two extra codons (dsiRNA-resistant site 50-GCACGT
GAGCTTGAAGGAA-30, nucleotides 2678-2676). While confirming the accuracy of the mutagenesis by sequencing, we detected a
deletion of amino acids 910 to 1120 in the KNL1 constructs used previously, probably caused by Nijenhuis et al. (2014). This occurred
between identical MELT13/17 sequences andwas probably caused by recombination of the plasmid during bacterial culture. To cor-
rect this, a 3991 bp fragment (corresponding to nucleotides 2730-6720 in KNL1WT plasmid) was amplified from genomic DNA of RPE
cells and subcloned into the pcDNA5-YFP-KNL1WT plasmid already containing the improved siRNA-resistant site. Gibson assembly
was then performed to correct all KNL1 constructs by replacing the N terminus through XhoI and PmlI restriction sites using pcDNA5-
YFP-KNL1PP1(2A) and pcDNA5-YFP-KNL1DPP1 as PCR templates. pcDNA5-YFP-KNL1 DNT (with deletion of the first 70 amino acids of
KNL1) was also created by Gibson assembly using the same restriction sites.
pcDNA5-YFP-B56g1-KNL1
DNT (KNL1 DNT fused to B56g1) and pcDNA5-YFP-B56g1
CD-KNL1DNT (KNL1 DNT fused to a version of
B56g1 with a S296Dmutation that disrupts PP2A binding (Vallardi et al., 2019)) were produced by restriction cloning using fragments
generated by PCR from pcDNA5-YFP-B56g1 and pcDNA5-YFP-B56g1
CD, respectively (Vallardi et al., 2019), both were inserted
using NotI and KasI restriction sites creating a 28 amino acid linker before KNL1 DNT. To create pcDNA5-YFP-KNL1 DNT-PP1mid a frag-
ment containing the PP1-binding SILK and RVSFmotifs (amino acids 24 to 70 of KNL1WT) was inserted at a BlpI site of pcDNA5-YFP-
KNL1 DNT by Gibson assembly (between MELT-10 andMELT-11). pcDNA5-YFP-BUBR1DCT-PP1:KNL1 was created by Gibson assem-
bly of two PCR fragments: pcDNA5-YFP-BUBR1 DCT (amplified from pcDNA5-YFP-BUBR1WT) and a fragment containing the first
70 amino acids of the N-terminal tail of KNL1 with the Aurora B sites mutated in the SLiM (amplified from pcDNA5-YFP-KNL1PP1(2A))
(a 6 amino acid linker connects BUBR1DCT to the N-terminal tail of KNL1). The same subcloning strategy was used to create pcDNA5-
YFP-BUBR1DCT-KNL1 but using a mutated N-terminal tail of KNL1 which cannot recruit PP1 (amplified from pcDNA5-YFP-KNL1DPP1).
pcDNA5-YFP-BUBR1DCT-B56g1 was also subcloned with the same strategy but using a fragment containing B56 amplified from
pcDNA5-YFP-B56g1 (Vallardi et al., 2019), inserting B56g1 and a 7 amino acid linker after amino acid 658 of BUBR1.
pcDNA4-mTurquoise2(Turq2)-BUBR1WT was created by Gibson assembly of 3 PCR fragments: pcDNA4 backbone, a fragment
containing BUBR1WT (amplified from pcDNA5-YFP- BUBR1WT) and a fragment containing mTurquoise2. pcDNA5-Turq2-
BUBR1 deP-PP2A was created by restriction cloning using Acc65I and BstBI to replace the YFP originally present in pcDNA5-YFP-
BUBR1 deP-PP2A (Turq2 subcloned from pcDNA4-Turq2-BUBR1WT). Similarly, Turq2-tagged version of BUBR1DCT-B56g1 was
created by restriction cloning using NheI and NotI to remove YFP. A pcDNA4-Turq2 version of BUBR1DCT was created by restriction
cloning using BstBI and HpaI to replace BUBR1WT from the original pcDNA4-Turq2-BUBR1WT vector. In the same way, pcDNA4-
Turq2-BUBR1Long was created by restriction cloning using BstBI and Bsu36I, and pcDNA4-Turq2 versions of BUBR1DCT-PP1:KNL1
and BUBR1DCT-KNL1 were created by restriction cloning using BstBI and NotI. pMESVJ-mCherry-B56g1 was produced by Gibson
assembly of pMESVJ-mCherry backbone (amplified from pMESVJ-mCherry-CenpB-Mad1 (Maldonado and Kapoor, 2011)) ande3 Cell Reports 28, 2206–2219.e1–e8, August 20, 2019
B56g1 (amplified from pcDNA5-YFP-B56g1) (Vallardi et al., 2019). pcDNA3-2xRFP-PP1 g was cloned previously (Nijenhuis et al.,
2014). All plasmids were fully sequenced to verify the transgene was correct.
Gene expression
HeLa Flp-in cells stably expressing doxycycline-inducible constructs were derived from the HeLa Flp-in cell line by transfection with
the relevant pcDNA5/FRT/TO vector and the Flp recombinase pOG44 (Thermo Fisher). Cells were subsequently selected in media
containing 200 mg/ml hygromycin B (Santa Cruz biotechnology) for at least 2 weeks to select for stable integrants at the FRT locus.
Cells expressing mCherry-B56g1 in combination with YFP-tagged KNL1
WT/DPP1 were generated by viral-integration of pMESVJ-
mCherry-B56g1 construct into the genome of HeLa Flp-in cells, followed by puromycin selection (1mg/ml, Santa Cruz biotechnology)
and were then transfected as above with YFP-KNL1WT/DPP1. Double mutant analysis was performed using cells that express a com-
bination of Turq2-taggedBUBR1 and YFP-tagged KNL1. Thesewere generated by transient transfection of Turq2-tagged constructs
into cells that were stably expressing doxycycline-inducible YFP-tagged recombinant proteins (generated as described above).
These Turq2-tagged constructs were transfected 32 hours prior to endogenous gene knock-down (described below) and at least
72 hours prior to imaging or fixation. PP1g localization was examined using RFP-tagged PP1g transiently transfect into YFP-
BUBR1 cell lines 32 hours prior to knockdown/replacement of BUBR1. Plasmidswere transfected into HeLa Flp-in cells using Fugene
HD (Promega) according to the manufacturer’s instructions.
Gene knockdown
For all experiments involving re-expression of BUBR1 or KNL1 in HeLa Flp-in cells, the endogenous mRNA was knocked down and
replaced with an siRNA-resistant mutant. To knockdown endogenous BUBR1 or KNL1 or both together, cells were transfected with
20nM BUBR1 siRNA (50- AGAUCCUGGCUAACUGUUC 30) (Sigma-Aldrich) or 20nM KNL1 dsiRNA (sense: 50-GCAUGUAUCU
CUUAAGGAAGAUGAA-30; antisense: 50-UUCAUCUUCCUUAAGAGAUACAUGCAU-30) (Integrated DNA technologies) or both
simultaneously for 16 h after which the cells were arrested in early S phase by addition of thymidine (2mM, Sigma-Aldrich) for
24 h. All siRNAs were transfected using Lipofectamine RNAiMAX Transfection Reagent (Life Technologies) according to the man-
ufacturer’s instructions. BUBR1 and KNL1 construct expression was induced by the addition of doxycycline (1mg/ml, Sigma-Aldrich)
during and following the thymidine block. After thymidine block, cells were release into media supplemented with doxycycline and,
where appropriate, nocodazole (3.3 mM, Sigma-Aldrich) for 5-7 hours for live imaging or 8.5 hours for fixed analysis. MPS1 and Aurora
B were inhibited by adding AZ-3146 (Sigma-Aldrich) and/or ZM-447439 (Cayman Chemicals) shortly prior to live cell imaging. For
kinase inhibition in cells analyzed by immunofluorescence, nocodazole andMG132 (10 mM,Sigma-Aldrich) were added first for 30mi-
nutes, followed by a time-course of AZ-3146 and/or ZM-447439 with nocodazole and MG132.
Immunofluorescence
Cells, plated on High Precision 1.5H 12-mm coverslips (Marienfeld), were fixed with 4% paraformaldehyde (PFA) in PBS for 10 min or
pre-extracted (when using pRVSF-KNL1 or mCherry antibodies) with 0.1% Triton X-100 in PEM (100 mM Pipes, pH 6.8, 1 mMMgCl2
and5mMEGTA) for 1minute before addition of 4%PFA for 10minutes.CoverslipswerewashedwithPBSandblockedwith 3%BSA in
PBS+0.5%TritonX-100 for 30min, incubatedwith primary antibodies overnight at 4C,washedwithPBSand incubatedwith second-
ary antibodies plus DAPI (4,6- diamidino2-phenylindole, Thermo Fisher) for an additional 2-4 hours at room temperature in the dark.
Coverslips were then washed with PBS and mounted on glass slides using ProLong antifade reagent (Molecular Probes). All images
were acquired on a DeltaVisionCore or Elite system equippedwith a heated 37Cchamber, with a 100x/1.40NAUPlan S Apochromat
objective using softWoRx software (Applied precision). Images were acquired at 1x1 binning using a CoolSNAP HQ or HQ2 camera
(Photometrics) andprocessed using softWorx software and ImageJ (National Institutes ofHealth). All immunofluorescence imagesdis-
played aremaximum intensity projections of deconvolved stacks andwere chosen tomost closely represent themeanquantified data.
Chromosome alignment assays
To observe chromosome alignment, cells were released from thymidine block for 7 hours before being synchronized at the G2/M
boundary with a 2-hour treatment with RO-3306 (10 mM, Tocris). Cells were then washed three times and incubated for 15 minutes
with full growthmedia before addition of MG132 for 30minutes to prevent mitotic exit. Cells were then fixed and stained as described
above and scored based on the number of misaligned chromosomes as aligned (0 misaligned chromosomes), mild (1-2), moderate
(3-5) or severe (> 6). This protocol is important becausemutants that cause a prolonged arrest can otherwise cause cohesion fatigue,
which skews the alignment data.
Time-lapse analyses
For fluorescence imaging, cells were imaged in 8-well chamber slides (ibidi) in Leibovitz L-15media with a heated 37C chamber or in
DMEM (no phenol red) with a heated 37Cchamber in 5%CO2. Imageswere taken every 4minuteswith either a 20x /0.4 NA air objec-
tive using a Zeiss Axio Observer 7 with a CMOS Orca flash 4.0 camera at 4x4 binning or a 40x/1.3 NA oil objective using a DV Elite
system equipped with Photometrics CascadeII:1024 EMCCD camera at 4x4 binning. For brightfield imaging, cells were imaged in
a 24-well plate in DMEM in a heated chamber (37C and 5%CO2) with a 10x/0.5 NA objective using a Hamamatsu ORCA-ER camera
at 2x2 binning on a Zeiss Axiovert 200M, controlled by Micro-manager software (open source: https://micro-manager.org/) or with aCell Reports 28, 2206–2219.e1–e8, August 20, 2019 e4
20x/0.4 NA air objective using a Zeiss Axio Observer 7 as detailed above.Mitotic exit was defined by cells flattening down in the pres-
ence of nocodazole and MPS1 inhibitor. In assays where both recombinant BUBR1 and KNL1 are expressed in cells, cells were
selected for quantification based on high levels of Turq2 as an indication of successful transient transfection of Turq2-BUBR1 con-
structs into cells stably expressing YFP-tagged KNL1 constructs.
Antibodies
All antibodies were diluted in 3% BSA in PBS. The following primary antibodies were used for immunofluorescence imaging (at the
final concentration indicated): chicken a-GFP (ab13970 from Abcam, 1:5000), mouse a-GFP (clone 4E12/8, a gift from P. Parker,
1:1000), rabbit a-pNDC80 Serine 55 (GTX70017 fromGeneTex, 1:1000), guinea pig a-Cenp-C (BT20278 from Caltag +Medsystems,
1:5000), rabbit a -BUB1 (A300-373A from Bethyl, 1:1000), mouse a-BUBR1 (A300-373A from Millipore, 1:1000), rabbit a-mCherry
(GTX128508, Genetex,1:1000). The rabbit a-pMELT-KNL1 antibody is directed against Thr 943 and Thr 1155 of human KNL1 (Nijen-
huis et al., 2014) (Gift from G.Kops, Hubrecht, NL). The pRVSF-KNL1 (pSer60-KNL1) antibody (custom rabbit polyclonals, gift from I.
Cheeseman, MIT, USA) was used at 1:2000 dilution (Nijenhuis et al., 2014). Secondary antibodies used were highly-cross absorbed
goat, a-chicken, a-rabbit, a-mouse or a-guinea pig coupled to Alexa Fluor 488, Alexa Fluor 568, or Alexa Fluor 647 (Thermo Fisher).
Mathematical modeling approach, terminology and assumptions
The model consists of a set of ordinary differential equations (ODEs) that correspond to the diagram in Figure 5A. All binding/disso-
ciation and phosphorylation/dephosphorylation reactions were modeled according to simple mass-action kinetics.
In the following, ‘‘½X’’ stands for the amount of species X. If X is an ‘atomic’ species (i.e., corresponding to one of the individual
rectangular boxes in Figure 5A), then ‘‘½Xtot’’ denotes the total amount of species X, including phosphorylated forms and all com-
plexes that contain X as a component, while ‘‘½Xfree’’ stands for the amount of X that is unbound and unphosphorylated. ‘‘pX’’ stands
for the phosphorylated form of X and ‘‘X : Y’’ for a form in which species X and Y are bound. Binding/dissociation rates for species X
are referred to as ‘‘kbX’’ and ‘‘kdX’’ and phosphorylation/dephosphorylation rates as ‘‘kpX’’ and ‘‘kdpX,’’ respectively.
Using ODEsmeans that the behavior of individual molecules is not represented and that all species are assumed to be well-mixed.
Thus, effectively the model describes the processes occurring on all KNL1molecules located on one representative kinetochore. We
assume that the total amounts for all species are conserved, except for MPS1 and Aurora B whose amounts can be changed exter-
nally to simulate the experimental inhibition of kinases. Furthermore, we assume that BUBR1 can be phosphorylated both in its free
form andwhen bound to pMELT but allow that thismay happenwith different rates (corresponding to the parameters kpBUBR1ðfreeÞ and
kpBUBR1). PP1 and PP2A are assumed to be catalytically active only when bound to KNL1 (via RVSF and pMELT:pBUBR1, respec-
tively). In reality, PP2A can also bind to unphosphorylated BUBR1, but we neglect this possibility because phos- phorylation byCDK1
and PLK1 increases the binding affinity by 11-fold and 5-fold, respectively (Wang et al., 2016a). To keep the model as simple as
possible we assumed that one phosphorylation event (CDK1) is needed to allow PP2A binding. For brevity, the active phosphatases
are denoted by ‘‘PP1act’’ and ‘‘PP2act.’’
The assumption of no substrate specificity means that PP1 and PP2A act on the same substrates (pMELT, pRVSF, pMELT:
pBUBR1, and pNDC80) and that for each substrate there is only one parameter describing the catalytic activities of both.
Modeling equations
The model can be described using a set of nine equations:
d½PP1act
dt
= kbPP1,½RVSF,½PP1free  kdPP1½PP1actd½PP2Aact
dt
= kbPP2A,½pMELT : pBUBR1,½PP2Afree+ kbBUBR1½pBUBR1 : PP2A,½pMELT  kdPP2A,½PP2Aact  kdBUBR1,½PP2Aactd½pBUBR1free
dt
= kdBUBR1,½pMELT : BUBR1+ kdPP2A½pBUBR1 : PP2A+ kpBUBR1ðfreeÞ,½BUBR1free,½CDK1
 kbBUBR1,½BUBR1free,½pMELT  kbPP2A,½pBUBR1free,½PP2Afreed½pBUBR1 : PP2A
dt
= kbPP2A,½pBUBR1free,½PP2Afree+ kdBUBR1,½PP2Aact  kdPP2A,½pBUBR1 : PP2A
 kbBUBR1,½pBUBR1 : PP2A,½pMELT
d½pMELT
dt
= kdBUBR1,½pMELT : BUBR1+ kdBUBR1,½pMELT : pBUBR1+ kdBUBR1,½PP2Aact+ kpMELT,½MELT,½MPS1
 kbBUBR1,½BUBR1free,½pMELT  kbBUBR1,½pBUBR1free,½pMELT  kbBUBR1,½pBUBR1 : PP2A,½pMELT
 kdpMELT,½pMELT,ð½PP1act+ ½PP2AactÞe5 Cell Reports 28, 2206–2219.e1–e8, August 20, 2019
d½pMELT : BUBR1
dt
= kbBUBR1,½BUBR1free,½pMELT+ kdpBUBR1,½pMELT : pBUBR1,ð½PP1act+ ½PP2AactÞ
 kdBUBR1,½pMELT : BUBR1  kpBUBR1,½pMELT : BUBR1,½CDK1d½pMELT : pBUBR1
dt
= kbBUBR1,½pBUBR1free,½pMELT+ kpBUBR1,½pMELT : BUBR1,½CDK1+ kdPP2A,½PP2Aact
 kdBUBR1,½pMELT : pBUBR1  kdpBUBR1,½pMELT : pBUBR1,ð½PP1act+ ½PP2AactÞ
 kbPP2A,½pMELT : pBUBR1,½PP2Afreed½pRVSF
dt
= kpRVSF,½RVSF,½AurB  kdpRVSF,½pRVSF,ð½PP1act+ ½PP2AactÞd½pNDC80
dt
= kpNDC80,½NDC80,½AurB  kdpNDC80,½pNDC80,ð½PP1act+ ½PP2AactÞFree amounts and total amounts for the modeling
The free amounts can be determined by the following algebraic relations, given that the total amounts are conserved:
½PP1free = ½PP1tot  ½PP1act½PP2Afree = ½PP2Atot  ½PP2Aact  ½pBUBR1 : PP2A  ½BUBR1 : PP2A½BUBR1free = ½BUBR1tot  ½pBUBR1free  ½pMELT : BUBR1  ½pMELT : pBUBR1  ½pBUBR1 : PP2A  ½BUBR1 : PP2A
 ½PP2Aact½MELTfree = ½MELTtot  ½pMELT  ½pMELT : BUBR1  ½pMELT : pBUBR1  ½PP2Aact½RVSFfree = ½RVSFtot  ½pRVSF  ½PP1act½NDC80free = ½NDC80tot  ½pNDC80
In order to compare themodel results to the experimental measurements, we defined the total amount of phosphorylatedMELT as an
auxiliary variable in the following way:
½pMELTtot = ½pMELT+ ½pMELT : BUBR1+ ½pMELT : pBUBR1+ ½PP2Aact
The fixed total amounts were chosen according to the following assumptions: First, there are multiple MELT motifs, but only one
RVSF site on each KNL1 molecule. Second, the species that bind to these motifs are available in sufficient amounts to potentially
‘saturate’ the motifs. Finally, total amounts for PP1 and PP2A are equal.
The choice of units is arbitrary becausewe only used relative amounts when comparing themodel output to experimental data, and
for clarity we leave out all units in the following. The values for the external kinases (MPS1, Aurora B, and CDK1) can be chosen arbi-
trarily without loss of generality because their activities are separately determined by fitting the respective parameters.
Given these assumptions, we chose the following values:Species Amount
½PP1tot 10
½PP2Atot 10
½MELTtot 10
½BUBR1tot 10
½RSVFtot 1
½NDC80tot 1
½MPS1 1
½Aurb 1
½CDK1 1
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Implementation of mutants and parameter optimization
The remaining parameters were determined by fitting simulated time courses of ½pMELTtot to two pieces of data. The first were the
experimental data from Figure 1c-f. More specifically, we started the simulations from the steady state corresponding to a condition
of metaphase arrest (½MPS1 = ½AurB = 1) and set either ½MPS1= 0 or ½MPS1 = ½AurB = 0. The WT condition corresponds to the
model as defined above, the DPP2A and DPP1 mutants were implemented by setting ½PP2Atot and ½PP1tot = 0, respectively. Initial
amounts for ½pMELTtotwere fit to bez50% of ½MELTtot in WT,z80% in DPP2A, andz100% in DPP1. To be able to investigate the
contribution of negative feedback in a more fine-grained way, parameters were additionally fit to the data in Figure S5. Here, we
considered ½PP2Aact as a readout for B56g. The B56gCD mutant was implemented by replacing all occurrences of the sum
½PP1act+ ½PP2Aact in the above equations by ½PP1act.
Based on these data, we obtained the following parameter set:Parameter Value
kbPP1 0.13
kdPP1 0.20
kbPP2A 0.32
kdPP2A 1.86
kbBUBR1 0.18
kdBUBR1 14.21
kpBUBR1 0.076
kpBUBR1ðfreeÞ 0.0076
kdpBUBR1 3.35
kpMELT 0.37
kdpMELT 0.70
kpRVSF 72.91
kdpRVSF 11.95For Figure 5E the BUBR1-PP2A mutant was implemented by assuming that BUBR1 phosphorylation and PP2A binding are quasi-
instantaneous and irreversible (setting kpBUBR1 = kpBUBR1 ðfreeÞ = kbPP2A = 10:000 and kdpBUBR1 = kdPP2A = 0). The KNL1-PP2A
mutant was implemented by setting kbPP2A = kdPP2A = 0and using a fixed amount of ½PP2Aact = 1, which corresponds to one
copy of PP2A per molecule of KNL1. The curves in Figure 5E were generated by calculating the steady state value of ½pMELTtot 
for different levels of ½MPS1. Sensitivity is commonly defined as the slope in a logarithmic plot (Ferrell and Ha, 2014).
Computational methods
The model was implemented in the Systems Biology Markup Language (SBML) and is available in Data S1. Parameter fitting and
simulations were performed using the Python package SloppyCell (Myers et al., 2007) and further analyzed using custom scripts writ-
ten in Python.
Motif analysis
A set of PP1-binding peptides for the RVxF-binding pocket and PP2A-B56-binding peptides for the LxxIxE-binding pocket were
created from experimentally validated peptides in the PP1 and PP2A literature. The dataset contained 110 RVxF and 27 LxxIxE mo-
tifs. A position-specific scoringmatrix (PSSM) was constructed from each set of peptides based on amino acid frequencies weighted
using peptide similarity weights and pseudocounts using the PSI BLAST IC scoring scheme as defined in the PSSMSearch tool (Alt-
schul et al., 1997; Krystkowiak et al., 2018). Each PSSM was screened against the human UniProt reviewed proteins using
PSSMSearch (Krystkowiak et al., 2018) and filtered using PSSM score p value with a cut-off of 0.0001, taxonomic range based
on conservation of the consensus outside themammalian clade, localization based on intracellular localization GO terms, and acces-
sibility based on: (i) overlap with a resolved region in a structure from PDB, (ii) intrinsic disorder predictions (retaining only peptides
found in disordered regions as defined by an IUPred score < 0.3 [15769473]) and (iii) UniProt annotation of topologically inaccessible
regions (e.g., transmembrane and extracellular regions) [25348405]. Applying these criteria, we produced sets of predicted 344
RVxF-binding and 210 PP2A-B56-binding motifs (Table S1). The phosphorylated (experimentally validated phosphorylation sites an-
notated in the UniProt, phospho.ELM or phosphosite databases) or phosphorylatable (any serine or threonine) residues within the
predicted and validated sets were collected and the kinase specificity of each site was annotated as basophilic ([KR]xS or [KR]
xxS), acidophilic ([DEN]x[ST]) or proline-directed ([ST]P). Enrichment of motif specificity determinants were calculated as the binomial
probability (probaa = binomial(k,n,p)) where k is the observed residue count at each position for a residue, n is the number of the
instances of motifs and p is the background amino acid frequency of a residue based on the disordered regions of the humane7 Cell Reports 28, 2206–2219.e1–e8, August 20, 2019
proteome. Enrichment of groupings (KR - basic, DE - acidic, ST - phosphorylatable by serine/threonine kinases) was calculated simi-
larly. RVxF-binding motifs are available at http://slim.ucd.ie/motifs/pp1/index.php?page=instances and PP2A-B56-binding motifs
are available at http://slim.ucd.ie/pp2a/index.php?page=instances
QUANTIFICATION AND STATISTICAL ANALYSIS
For quantification of immunostainings, all images of similarly stained experiments were acquired with identical illumination settings
and cells expressing comparable levels of exogenous protein were selected and analyzed using ImageJ. An ImageJmacro was used
to threshold and select all kinetochores and all chromosome areas (excluding kinetochores) using theDAPI and anti-kinetochore anti-
body channels, as previously (Saurin et al., 2011). This was used to calculate the relative mean kinetochore intensity of various pro-
teins ([kinetochores-chromosome arm intensity (test protein)] / [kinetochores-chromosome arm intensity (CENP-C)]. To quantify
RFP-PP1g levels, a 10 3 0.2 mM z stack projection of kinetochore rich z sections were used. Following imaging, any cells that
were not in focus or out of view were excluded from the analysis.
Two-tailed, unpaired t testswithWelch’s correction were performed to compare themeans values between experimental groups in
immunofluorescence quantifications (using Prism 6 software). The raw data for all experiments and the actual statistical values can
be found in Data S2.
DATA AND CODE AVAILABILITY
The published article contains all the datasets generated in Data S2 and the code for the model data is available in SBML format in
Data S1.Cell Reports 28, 2206–2219.e1–e8, August 20, 2019 e8
